This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The single-award IDC, valued at up to $6,984,109.81, has an ultimate completion date of February 11, 2029.
Under this contract, Exelan Pharmaceuticals will provide a variety of generic pharmaceutical products to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through the DLA and VA prime vendor programs. The contracted items include different dosage forms and package sizes of ibuprofen, as well as other generic medications like escitalopram oxalate, oseltamivir phosphate, prazosin HCL, sildenafil citrate, and zonisamide. Exelan will also support the VA's Pharmaceutical Repackaging Program by repackaging bulk drug products into individual prescriptions at its facility in Boca Raton, Florida. This IDC was competitively awarded without any set-aside designations, and the majority of the funding will come from the VA National Acquisition Center and the Defense Logistics Agency Troop Support Medical.
Generated 8/20/24, 9:12 AM